Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Aug;21(8):2908.
doi: 10.1111/ajt.16687. Epub 2021 Jun 4.

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm

Affiliations
Comment

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: No cause for alarm

Sherif Beniameen Mossad. Am J Transplant. 2021 Aug.
No abstract available

Keywords: clinical research/practice; infection and infectious agents; infectious disease; vaccine.

PubMed Disclaimer

Comment in

Comment on

References

    1. Grupper A, Rabinowich L, Schwartz D, et al. Reduced humoral response to mRNA SARS-Cov-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. Accepted Author Manuscript. 2021. 10.1111/ajt.16615 [Epub ahead of print]. - DOI - PMC - PubMed
    1. Chen Y, Li P, Ding Y-B, et al. Epidemiological feature, viral shedding, and antibody seroconversion among asymptomatic SARS-CoV-2 carriers and symptomatic/presymptomatic COVID-19 patients. medRxiv. 2020.12.18.20248447. 10.1101/2020.12.18.20248447. - DOI - PMC - PubMed
    1. Walsh EE, Frenck RW, Falsey AR, et al. Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates. N Engl J Med. 2020;383:2439–2450. - PMC - PubMed
    1. Overall immune profile and effect of chronic kidney disease on vaccination schedule. Indian J Nephrol. 2016;26(suppl 1):S2–S4.
    1. Baker D, Roberts CAK, Pryce G, et al. COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases. Clin Exp Immunol. 2020;202(2):149–161. - PMC - PubMed